CALQUENCE - Acalabrutinib- (Oct 2017) -Tp treat mantle cell lymphoma

Drug Name:
CALQUENCE - Acalabrutinib- (Oct 2017) -Tp treat mantle cell lymphoma

List Of Brands:

Indication Type Description:

Drug Interaction

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Patient Information

Pharmacology/ Pharmacokinetics

Pregnancy and lactation

   

Drug Interaction:

DRUG INTERACTIONS- summary

CYP3A Inhibitors: Avoid co-administration with strong CYP3A inhibitors. Dose adjustments may be recommended.

CYP3A Inducers: Avoid co-administration with strong CYP3A inducers. Dose adjustments may be recommended.

Gastric Acid Reducing Agents: Avoid co-administration with proton pump inhibitors (PPIs).

Stagger dosing with H2-receptor antagonists and antacids.